The DOI matches its Crossref record; 143 of the 143 references it cites were found in a registry or an index.
Role of the Matrix Metalloproteinase and Plasminogen Activator–Plasmin Systems in Angiogenesis
Abstract
Abstract—Extracellular proteolysis is an absolute requirement for new blood vessel formation (angiogenesis). This review examines the role of the matrix metalloproteinase (MMP) and plasminogen activator (PA)–plasmin systems during angiogenesis. Specifically, a role for gelatinases (MMP-2, MMP-9), membrane-type 1 MMP (MMP-14), the urokinase-type PA receptor, and PA inhibitor 1 has been clearly defined in a number of model systems. The MMP and PA-plasmin systems have also been implicated in experimental vascular tumor formation, and their role during this process will be examined. Antiproteolysis, particularly in the context of angiogenesis, has become a key target in therapeutic strategies aimed at inhibiting tumor growth and other diseases associated with neovascularization.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth
O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., & Folkman, J. (1997) · Cell · doi:10.1016/s0092-8674(00)81848-6 · Cited by 4,486
O'Reilly, M. (1994) · Cell · doi:10.1016/0092-8674(94)90200-3 · Cited by 3,345
A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells
Black, R. A., Rauch, C. T., Kozlosky, C. J., Peschon, J. J., Slack, J. L., Wolfson, M. F., Castner, B. J., Stocking, K. L., Reddy, P., Srinivasan, S., et al. (1997) · Nature · doi:10.1038/385729a0 · Cited by 3,149
Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
Bergers, G., Brekken, R., McMahon, G., Vu, T. H., Itoh, T., Tamaki, K., Tanzawa, K., Thorpe, P., Itohara, S., Werb, Z., et al. (2000) · Nature Cell Biology · doi:10.1038/35036374 · Cited by 2,797
Tissue inhibitors of metalloproteinases: evolution, structure and function
Brew, K., Dinakarpandian, D., & Nagase, H. (2000) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(99)00279-4 · Cited by 1,908
Vu, T. H., Shipley, J. M., Bergers, G., Berger, J. E., Helms, J. A., Hanahan, D., Shapiro, S. D., Senior, R. M., & Werb, Z. (1998) · Cell · doi:10.1016/s0092-8674(00)81169-1 · Cited by 1,750
Holmbeck, K., Bianco, P., Caterina, J., Yamada, S., Kromer, M., Kuznetsov, S. A., Mankani, M., Gehron Robey, P., Poole, A. R., Pidoux, I., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80064-1 · Cited by 1,298
Matrix metalloproteinases: effectors of development and normal physiology
Vu, T. H., & Werb, Z. (2000) · Genes & Development · doi:10.1101/gad.815400 · Cited by 1,235
Houck, K. A., Leung, D. W., Rowland, A. M., Winer, J., & Ferrara, N. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35712-0 · Cited by 1,127
The plasminogen activation system in tumor growth, invasion, and metastasis
Andreasen, P. A., Egelund, R., & Petersen, H. H. (2000) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s000180050497 · Cited by 943
Reduced angiogenesis and tumor progression in gelatinase A-deficient mice.
Itoh, T., Tanioka, M., Yoshida, H., Yoshioka, T., Nishimoto, H., & Itohara, S. (1998) · PubMed · Cited by 875
Pepper, M. S., Ferrara, N., Orci, L., & Montesano, R. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)92277-5 · Cited by 858
Self-citationMatrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention
Stetler-Stevenson, W. G. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6870 · Cited by 842
Griffioen, A. W., & Molema, G. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01448-0 · Cited by 842
Development of Matrix Metalloproteinase Inhibitors in Cancer Therapy
Hidalgo, M., & Eckhardt, S. G. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.3.178 · Cited by 798
Heymans, S., Luttun, A., Nuyens, D., Theilmeier, G., Creemers, E., Moons, L., Dyspersin, G. D., Cleutjens, J. P. M., Shipley, M., Angellilo, A., et al. (1999) · Nature Medicine · doi:10.1038/13459 · Cited by 794
Inflammation Dampened by Gelatinase A Cleavage of Monocyte Chemoattractant Protein-3
McQuibban, G. A., Gong, J.-H., Tam, E. M., McCulloch, C. A. G., Clark-Lewis, I., & Overall, C. M. (2000) · Science · doi:10.1126/science.289.5482.1202 · Cited by 772
Dvorak, H. F., Nagy, J. A., Feng, D., Brown, L. F., & Dvorak, A. M. (1999) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-59953-8_6 · Cited by 743
Matrix Metalloproteinases Regulate Neovascularization by Acting as Pericellular Fibrinolysins
Hiraoka, N., Allen, E., Apel, I. J., Gyetko, M. R., & Weiss, S. J. (1998) · Cell · doi:10.1016/s0092-8674(00)81768-7 · Cited by 712
Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization
Bajou, K., Noël, A., Gerard, R. D., Masson, V., Brunner, N., Holst-Hansen, C., Skobe, M., Fusenig, N. E., Carmeliet, P., Collen, D., et al. (1998) · Nature Medicine · doi:10.1038/nm0898-923 · Cited by 677
Zhou, Z., Apte, S. S., Soininen, R., Cao, R., Baaklini, G. Y., Rauser, R. W., Wang, J., Cao, Y., & Tryggvason, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.060037197 · Cited by 666
Brooks, P. C., Silletti, S., von Schalscha, T. L., Friedlander, M., & Cheresh, D. A. (1998) · Cell · doi:10.1016/s0092-8674(00)80931-9 · Cited by 623
Asahara, T., Bauters, C., Zheng, L. P., Takeshita, S., Bunting, S., Ferrara, N., Symes, J. F., & Isner, J. M. (1995) · Circulation · doi:10.1161/01.cir.92.9.365 · Cited by 596
Tumor targeting with a selective gelatinase inhibitor
Koivunen, E., Arap, W., Valtanen, H., Rainisalo, A., Medina, O. P., Heikkilä, P., Kantor, C., Gahmberg, C. G., Salo, T., Konttinen, Y. T., et al. (1999) · Nature Biotechnology · doi:10.1038/11703 · Cited by 567
Impaired wound healing in mice with a disrupted plasminogen gene
Rømer, J., Bugge, T. H., Fyke, C., Lund, L. R., Flick, M. J., Degen, J. L., & Danø, K. (1996) · Nature Medicine · doi:10.1038/nm0396-287 · Cited by 561
Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment
Zucker, S., Cao, J., & Chen, W.-T. (2000) · Oncogene · doi:10.1038/sj.onc.1204097 · Cited by 550
Vascular Endothelial Growth Factor: Molecular and Biological Aspects
Ferrara, N. (1999) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-59953-8_1 · Cited by 533
Unemori, E. N., Ferrara, N., Bauer, E. A., & Amento, E. P. (1992) · Journal of Cellular Physiology · doi:10.1002/jcp.1041530317 · Cited by 526
Dong, Z., Kumar, R., Yang, X., & Fidler, I. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81926-1 · Cited by 525
Canstatin, a Novel Matrix-derived Inhibitor of Angiogenesis and Tumor Growth
Kamphaus, G. D., Colorado, P. C., Panka, D. J., Hopfer, H., Ramchandran, R., Torre, A., Maeshima, Y., Mier, J. W., Sukhatme, V. P., & Kalluri, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.2.1209 · Cited by 475
Secreted cathepsin L generates endostatin from collagen XVIII
Felbor, U. (2000) · The EMBO Journal · doi:10.1093/emboj/19.6.1187 · Cited by 469
Goto, F., Goto, K., Weindel, K., & Folkman, J. (1993) · PubMed · Cited by 459
Montesano, R., Pepper, M. S., Möhle-Steinlein, U., Risau, W., Wagner, E. F., & Orci, L. (1990) · Cell · doi:10.1016/0092-8674(90)90009-4 · Cited by 454
Self-citationPepper, M. S., Belin, D., Montesano, R., Orci, L., & Vassalli, J. D. (1990) · The Journal of cell biology · doi:10.1083/jcb.111.2.743 · Cited by 453
Self-citationMignatti, P., Tsuboi, R., Robbins, E., & Rifkin, D. B. (1989) · The Journal of cell biology · doi:10.1083/jcb.108.2.671 · Cited by 453
Matrix Metalloproteinases Generate Angiostatin: Effects on Neovascularization
Cornelius, L. A., Nehring, L. C., Harding, E., Bolanowski, M., Welgus, H. G., Kobayashi, D. K., Pierce, R. A., & Shapiro, S. D. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.12.6845 · Cited by 444
Mechanisms for pro matrix metalloproteinase activation
MURPHY, G., STANTON, H., COWELL, S., BUTLER, G., KNÄUPER, V., ATKINSON, S., & GAVRILOVIC, J. (1999) · APMIS · doi:10.1111/j.1699-0463.1999.tb01524.x · Cited by 441
Forsyth, P. A., Wong, H., Laing, T. D., Rewcastle, N. B., Morris, D. G., Muzik, H., Leco, K. J., Johnston, R. N., Brasher, P. M. A., Sutherland, G., et al. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690291 · Cited by 436
Patterson, B. C., & Sang, Q. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.46.28823 · Cited by 433
Antiangiogenic Activity of the Cleaved Conformation of the Serpin Antithrombin
O'Reilly, M. S., Pirie-Shepherd, S., Lane, W. S., & Folkman, J. (1999) · Science · doi:10.1126/science.285.5435.1926 · Cited by 432
The Plasminogen (Fibrinolytic) System
Collen, D. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615841 · Cited by 430
Anti-angiogenic cues from vascular basement membrane collagen.
Colorado, P. C., Torre, A., Kamphaus, G. D., Maeshima, Y., Hopfer, H., Takahashi, K., Volk, R., Zamborsky, E. D., Herman, S., Sarkar, P. K., et al. (2000) · PubMed · Cited by 426
Mazzieri, R., Masiero, L., Zanetta, L., Monea, S., Onisto, M., Garbisa, S., & Mignatti, P. (1997) · The EMBO Journal · doi:10.1093/emboj/16.9.2319 · Cited by 422
Can a biologist fix a radio?—Or, what I learned while studying apoptosis
Lazebnik, Y. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00133-2 · Cited by 421
Lymphangiogenesis and tumor metastasis: myth or reality?
Pepper, M. S. (2001) · PubMed · Cited by 418
Self-citationExpression of matrix metalloproteinase-2 and -9 during early human wound healing.
Salo, T. A., Mäkelä, M., Kylmäniemi, M., Autio‐Harmainen, H., & Larjava, H. (1994) · PubMed · Cited by 406
Pozzi, A., Moberg, P. E., Miles, L. A., Wagner, S., Soloway, P., & Gardner, H. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040378497 · Cited by 395
Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model
Fang, J., Shing, Y., Wiederschain, D., Yan, L., Butterfield, C., Jackson, G., Harper, J., Tamvakopoulos, G., & Moses, M. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.8.3884 · Cited by 393
Ossowski, L., & Aguirre-Ghiso, J. A. (2000) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00140-x · Cited by 380
Generation and degradation of human endostatin proteins by various proteinases
Ferreras, M., Felbor, U., Lenhard, T., Olsen, B. R., & Delaissé, J.-M. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)02249-3 · Cited by 377
Matrix metalloproteinases in tumor invasion
Johansson, N. (2000) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s000180050495 · Cited by 371
Microscopic observations on the growth of blood capillaries in the living mammal
Clark, E. R., & Clark, E. L. (1939) · American Journal of Anatomy · doi:10.1002/aja.1000640203 · Cited by 370
Distinct Antitumor Properties of a Type IV Collagen Domain Derived from Basement Membrane
Maeshima, Y., Colorado, P. C., Torre, A., Holthaus, K. A., Grunkemeyer, J. A., Ericksen, M. B., Hopfer, H., Xiao, Y., Stillman, I. E., & Kalluri, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001956200 · Cited by 358
Itoh, T., Ikeda, T., Gomi, H., Nakao, S., Suzuki, T., & Itohara, S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.36.22389 · Cited by 356
Haas, T. L., Davis, S. J., & Madri, J. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.6.3604 · Cited by 351
Basement Membrane Collagen: Degradation by Migrating Endothelial Cells
Kalebic, T., Garbisa, S., Glaser, B., & Liotta, L. A. (1983) · Science · doi:10.1126/science.6190230 · Cited by 350
Kim, Y. M., Jang, J.-W., Lee, O., Yeon, J.-H., Choi, E.-Y., Kim, K., Lee, S., & Kwon, Y. (2000) · PubMed · Cited by 347
Complex role of matrix metalloproteinases in angiogenesis
Sang, Q. X. A. (1998) · Cell Research · doi:10.1038/cr.1998.17 · Cited by 332
Plasminogen Activators and Matrix Metalloproteinases in Angiogenesis
Mignatti, P., & Rifkin, D. B. (1996) · Enzyme and Protein · doi:10.1159/000468621 · Cited by 330
The generation of endostatin is mediated by elastase.
Wen, W. X., Moses, M. A., Wiederschain, D., Arbiser, J. L., & Folkman, J. (1999) · PubMed · Cited by 318
Bajou, K., Masson, V., Gerard, R. D., Schmitt, P. M., Albert, V., Praus, M., Lund, L. R., Frandsen, T. L., Brunner, N., Dano, K., et al. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.152.4.777 · Cited by 314
Vasostatin, a Calreticulin Fragment, Inhibits Angiogenesis and Suppresses Tumor Growth
Pike, S. E., Yao, L., Jones, K. D., Cherney, B., Appella, E., Sakaguchi, K., Nakhasi, H., Teruya-Feldstein, J., Wirth, P., Gupta, G., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2349 · Cited by 310
Membrane‐type matrix metalloproteinases
SEIKI, M. (1999) · APMIS · doi:10.1111/j.1699-0463.1999.tb01536.x · Cited by 300
The Regulation of Neovascularization by Matrix Metalloproteinases and Their Inhibitors
Moses, M. A. (1997) · STEM CELLS · doi:10.1002/stem.150180 · Cited by 298
Gerwins, P., Sköldenberg, E., & Claesson-Welsh, L. (2000) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(00)00062-7 · Cited by 290
Antiangiogenic Activity of Restin, NC10 Domain of Human Collagen XV: Comparison to Endostatin
Ramchandran, R., Dhanabal, M., Volk, R., Waterman, M. J. F., Segal, M., Lu, H., Knebelmann, B., & Sukhatme, V. P. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0248 · Cited by 290
Expression of matrix metalloproteinase 9 (96‐kd gelatinase B) in human rheumatoid arthritis
Ahrens, D., Koch, A. E., Pope, R. M., Stein‐Picarella, M., & Niedbala, M. J. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390919 · Cited by 284
Urokinase-type plasminogen activator is induced in migrating capillary endothelial cells.
Pepper, M. S., Vassalli, J. D., Montesano, R., & Orci, L. (1987) · The Journal of cell biology · doi:10.1083/jcb.105.6.2535 · Cited by 280
Self-citationLamoreaux, W. J., Fitzgerald, M. E. C., Reiner, A., Hasty, K. A., & Charles, S. T. (1998) · Microvascular Research · doi:10.1006/mvre.1997.2056 · Cited by 278
Zucker, S., Mirza, H., Conner, C. E., Lorenz, A. F., Drews, M. H., Bahou, W. F., & Jesty, J. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980302)75:5<780::aid-ijc19>3.0.co;2-a · Cited by 270
Upregulation of urokinase receptor expression on migrating endothelial cells
Pepper, M., Sappino, A., Stöcklin, R., Montesano, R., Orci, L., & Vassalli, J. (1993) · The Journal of cell biology · doi:10.1083/jcb.122.3.673 · Cited by 270
Self-citationSilletti, S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.011343298 · Cited by 262
Manipulating Angiogenesis: From Basic Science to the Bedside
Pepper, M. S. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.4.605 · Cited by 261
Self-citationThrombospondin Type 1 Repeats Interact with Matrix Metalloproteinase 2
Bein, K., & Simons, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003834200 · Cited by 255
Urokinase receptor antagonists inhibit angiogenesis and primary tumor growth in syngeneic mice.
Min, H. Y., Doyle, L. V., Vitt, C. R., Zandonella, C., Stratton-Thomas, J. R., Shuman, M. A., & Rosenberg, S. (1996) · PubMed · Cited by 242
Saarialho-Kere, U. K., Pentland, A. P., Birkedal-Hansen, H., Parks, W. C., & Welgus, H. G. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117351 · Cited by 237
Taraboletti, G., Garofalo, A., Belotti, D., Drudis, T., Borsotti, P., Scanziani, E., Brown, P. D., & Giavazzi, R. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.4.293 · Cited by 235
Two RGD-independent αvβ3 Integrin Binding Sites on Tumstatin Regulate Distinct Anti-tumor Properties
Maeshima, Y., Colorado, P. C., & Kalluri, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000186200 · Cited by 231
Davis, G. E., Allen, K. A. P., Salazar, R., & Maxwell, S. A. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.5.917 · Cited by 228
The Matrix Metalloproteinase Family
Woessner, J. F. (1998) · Matrix Metalloproteinases · doi:10.1016/b978-012545090-4/50002-1 · Cited by 217
Gutierrez, L. S., Schulman, A., Brito-Robinson, T., Noria, F., Ploplis, V. A., & Castellino, F. (2000) · PubMed · Cited by 217
Pepper, M. S., Montesano, R., Mandriota, S. J., Orci, L., & Vassalli, J.-D. (1996) · Enzyme and Protein · doi:10.1159/000468622 · Cited by 216
Self-citationUrokinase receptor: a molecular organizer in cellular communication
Preissner, K. T., Kanse, S. M., & May, A. E. (2000) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00141-1 · Cited by 209
Proteolytic balance and capillary morphogenesis
Pepper, M. S., & Montesano, R. (1990) · Cell Differentiation and Development · doi:10.1016/0922-3371(90)90046-y · Cited by 198
Self-citationHaas, T. L., Stitelman, D., Davis, S. J., Apte, S. S., & Madri, J. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.32.22679 · Cited by 188
Mandriota, S. J., & Pepper, M. S. (1997) · Journal of Cell Science · doi:10.1242/jcs.110.18.2293 · Cited by 187
Self-citationPepper, M. S., Mandriota, S. J., Jeltsch, M., Kumar, V., & Alitalo, K. (1998) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199812)177:3<439::aid-jcp7>3.0.co;2-2 · Cited by 186
Self-citationGeneration of an Angiostatin-like Fragment from Plasminogen by Stromelysin-1 (MMP-3)
Lijnen, H. R., Ugwu, F., Bini, A., & Collen, D. (1998) · Biochemistry · doi:10.1021/bi9731798 · Cited by 185
The extracellular regulation of growth factor action.
Flaumenhaft, R., & Rifkin, D. B. (1992) · Molecular Biology of the Cell · doi:10.1091/mbc.3.10.1057 · Cited by 177
Inhibition of Angiogenesis in Vivo by Plasminogen Activator Inhibitor-1
Stefansson, S., Petitclerc, E., Wong, M. K., McMahon, G. A., Brooks, P. C., & Lawrence, D. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007609200 · Cited by 177
Soff, G. A., Sanderowitz, J., Gately, S. T., Verrusio, E., Weiss, I., Brem, S. S., & Kwaan, H. C. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118323 · Cited by 173
Colman, R. W., Jameson, B. A., Lin, Y., Johnson, D., & Mousa, S. A. (2000) · Blood · doi:10.1182/blood.v95.2.543 · Cited by 171
MMP-2 Colocalizes with Caveolae on the Surface of Endothelial Cells
Puyraimond, A., Fridman, R., Lemesle, M., Arbeille, B., & Menashi, S. (2001) · Experimental Cell Research · doi:10.1006/excr.2000.5069 · Cited by 168
Extracellular Matrix-Driven Matrix Metalloproteinase Production in Endothelial Cells
Haas, T. L., & Madri, J. A. (1999) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(99)00014-6 · Cited by 164
Regulation of cell adhesion by PAI‐1
Loskutoff, D. J., Curriden, S. A., Hu, G., & Deng, G. (1999) · Apmis · doi:10.1111/j.1699-0463.1999.tb01526.x · Cited by 155
Pfeifer, A., Keßler, T., Silletti, S., Cheresh, D. A., & Verma, I. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.220399597 · Cited by 151
Lelongt, B., Bengatta, S., Delauche, M., Lund, L. R., Werb, Z., & Ronco, P. M. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.7.793 · Cited by 148
Tumour vasculature as a target for anticancer therapy
Eatock, M. M., Schätzlein, A. G., & Kaye, S. B. (2000) · Cancer Treatment Reviews · doi:10.1053/ctrv.1999.0158 · Cited by 139
Dow, J. K., & White, R. D. (2000) · Urology · doi:10.1016/s0090-4295(00)00457-x · Cited by 137
Tumor angiogenesis: the role of oncogenes and tumor suppressor genes.
BOUCK, N. P. (1990) · PubMed · Cited by 136
Anticancer drug targets: approaching angiogenesis
Keshet, E., & Ben‐Sasson, S. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci8849 · Cited by 135
Cornelius, L. A., Nehring, L. C., Roby, J. D., Parks, W. C., & Welgus, H. G. (1995) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12317080 · Cited by 134
Guo, Y., Higazi, A. A., Arakelian, A., Sachais, B. S., Cines, D., Goldfarb, R. H., Jones, T. R., Kwaan, H., Mazar, A. P., & Rabbani, S. A. (2000) · The FASEB Journal · doi:10.1096/fj.14.10.1400 · Cited by 130
Hydroxamate-type matrix metalloproteinase inhibitor batimastat promotes liver metastasis.
Krüger, A., Soeltl, R., Sopov, I., Kopitz, C., Arlt, M., Magdolen, V., Harbeck, N., Gänsbacher, B., & Schmitt, M. (2001) · PubMed · Cited by 127
Clinical studies with matrix metalloproteinase inhibitors
Brown, P. D. N. (1999) · Apmis · doi:10.1111/j.1699-0463.1999.tb01541.x · Cited by 126
Li, H., Lu, H., Griscelli, F., Opolon, P., Sun, L.-Q., Ragot, T., Legrand, Y., Belin, D., Soria, J., Soria, C., et al. (1998) · Gene Therapy · doi:10.1038/sj.gt.3300742 · Cited by 125
Montesano, R., Pepper, M. S., Vassalli, J. D., & Orci, L. (1987) · Journal of Cellular Physiology · doi:10.1002/jcp.1041320313 · Cited by 120
Self-citationJiang, Y., Wang, M., Celiker, M., Liu, Y., Sang, Q., Goldberg, I. D., & Shi, Y. E. (2001) · PubMed · Cited by 119
Stack, M. S., Gately, S. T., Bafetti, L. M., Enghild, J. J., & Soff, G. A. (1999) · Biochemical Journal · doi:10.1042/bj3400077 · Cited by 116
Guédez, L., McMarlin, A., Kingma, D. W., Bennett, T. A., Stetler‐Stevenson, M., & Stetler‐Stevenson, W. G. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64070-9 · Cited by 115
Matrix Metalloproteinases: Pro- and Anti-Angiogenic Activities
Raza, S. L., & Cornelius, L. A. (2000) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1046/j.1087-0024.2000.00004.x · Cited by 110
Lozonschi, L., Sunamura, M., Kobari, M., Egawa, S., Ding, L., & Matsuno, S. (1999) · PubMed · Cited by 107
In Vitro Angiogenic and Proteolytic Properties of Bovine Lymphatic Endothelial Cells
Pepper, M. S., Wasi, S., Ferrara, N., Orci, L., & Montesano, R. (1994) · Experimental Cell Research · doi:10.1006/excr.1994.1042 · Cited by 104
Self-citationPieces of eight: bioactive fragments of extracellular proteins as regulators of angiogenesis
(1997) · Trends in Cell Biology · doi:10.1016/s0962-8924(97)01037-4 · Cited by 104
Sato, Y., Okamura, K., Morimoto, A., Hamanaka, R., Hamaguchi, K., Shimada, T., Ono, M., Kohno, K., Sakata, T., & Kuwano, M. (1993) · Experimental Cell Research · doi:10.1006/excr.1993.1028 · Cited by 101
Uchiyama, T., Kurabayashi, M., Ohyama, Y., Utsugi, T., Akuzawa, N., Sato, M., Tomono, S., Kawazu, S., & Nagai, R. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.4.1155 · Cited by 96
Hajitou, A., Sounni, N. E., Devy, L., Grignet, C., Lewalle, J.-M., Li, H., Deroanne, C., Lu, H., Colige, A., Nusgens, B., et al. (2001) · PubMed · Cited by 95
Mishima, K., Mazar, A. P., Gown, A. M., Skelly, M., Ji, X.-D., Wang, X., Jones, T. R., Cavenee, W. K., & Huang, H. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.150239497 · Cited by 91
Kroon, M. E., Koolwijk, P., van der Vecht, B., & van Hinsbergh, V. W. M. (2000) · Blood · doi:10.1182/blood.v96.8.2775 · Cited by 90
Li, Y., Moses, M. A., Huang, S., & Ingber, D. E. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.22.3979 · Cited by 90
Plasminogen activators augment endothelial cell organization in vitro by two distinct pathways
Schnaper, H. W., Barnathan, E. S., Mazar, A. P., Maheshwari, S. R., Ellis, S., Cortez, S. L., Baricos, W. H., & Kleinman, H. K. (1995) · Journal of Cellular Physiology · doi:10.1002/jcp.1041650114 · Cited by 89
Okamura, K., Sato, Y., Matsuda, T., Hamanaka, R., Ono, M., Kohno, K., & Kuwano, M. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54976-0 · Cited by 79
In vivo angiogenic activity of urokinase: role of endogenous fibroblast growth factor-2
Ribatti, D., Leali, D., Vacca, A., Giuliani, R., Gualandris, A., Roncali, L., Nolli, M. L., & Presta, M. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.23.4213 · Cited by 74
Expression of Metalloproteinases and Their Inhibitors in Blood Vesselsin Human Endometrium1
Freitas, S., Méduri, G., Nestour, E. L., Bausero, P., & Perrot‐Applanat, M. (1999) · Biology of Reproduction · doi:10.1095/biolreprod61.4.1070 · Cited by 73
Iurlaro, Loverro, G., Vacca, Cormio, G., Ribatti, Minischetti, Ria, R., Bruno, & Selvaggi, F. (1999) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1999.00532.x · Cited by 72
Storage of Tissue-Type Plasminogen Activator in Weibel-Palade Bodies of Human Endothelial Cells
Rosnoblet, C., Vischer, U. M., Gerard, R. D., Irminger, J.-C., Halban, P. A., & Kruithof, E. K. O. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.7.1796 · Cited by 72
Kräling, B. M., Wiederschain, D., Boehm, T., Rehn, M., Mulliken, J. B., & Moses, M. A. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.10.1599 · Cited by 72
Maekawa, R., Maki, H., Yoshida, H., Hojo, K., Tanaka, H., Wada, T., Uchida, N., Takeda, Y., Kasai, H., Okamoto, H., et al. (1999) · PubMed · Cited by 66
Matrix Metalloproteinases in Blood Vessel Development in Human Fetal Skin and in Cutaneous Tumors
Karelina, T. V., Goldberg, G. I., & Eisen, A. Z. (1995) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12321097 · Cited by 56
Perivascular Cells Regulate Endothelial Membrane Type-1 Matrix Metalloproteinase Activity
Lafleur, M. A., Forsyth, P. A., Atkinson, S. J., Murphy, G., & Edwards, D. R. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4596 · Cited by 53
Therapeutic potentials of angiostatin in the treatment of cancer.
Cao, Y. (1999) · PubMed · Cited by 51
ROOPRAI, H. K., Meter, T. E. V., Rucklidge, G. J., Hudson, L., Everall, I., & Pilkington, G. J. (1998) · International Journal of Oncology · doi:10.3892/ijo.13.6.1153 · Cited by 42
Nguyen, M., Arkell, J., & Jackson, C. (2000) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(00)00013-3 · Cited by 42
Chan, V. T., Zhang, D. N., Nagaravapu, U., Hultquist, K., Romero, L. I., & Herron, G. S. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00416.x · Cited by 40
The regulatory effects of cytokines on lymphatic angiogenesis.
Liu, N. F., & He, Q. (1997) · PubMed · Cited by 31
Ito, K., Ryuto, M., Ushiro, S., Ono, M., Sugenoya, A., Kuraoka, A., Shibata, Y., & Kuwano, M. (1995) · Journal of Cellular Physiology · doi:10.1002/jcp.1041620207 · Cited by 30
Vagnoni, K. E., Zheng, J. J., & Magness, R. R. (1998) · Placenta · doi:10.1016/s0143-4004(98)91037-2 · Cited by 28
Human endothelial cells expressing polyoma middle T induce tumors
Primo, L., Roca, C., Ferrandi, C., Lanfrancone, L., & Bussolino, F. (2000) · Oncogene · doi:10.1038/sj.onc.1203708 · Cited by 26
Bacharach, E., Itin, A., & Keshet, E. (1998) · Blood · doi:10.1182/blood.v92.3.939 · Cited by 25
Targeting of a Heterologous Protein to a Regulated Secretion Pathway in Cultured Endothelial Cells
Datta, Y. H., Youssoufian, H., Marks, P. W., & Ewenstein, B. M. (1999) · Blood · doi:10.1182/blood.v94.8.2696.420k29_2696_2703 · Cited by 23
Endostatin: A Promising Drug for Antiangiogenic Therapy
Cirri, L., Donnini, S., Morbidelli, L., Chiarugi, P., Ziche, M., & Ledda, F. (1999) · The International Journal of Biological Markers · doi:10.1177/172460089901400412 · Cited by 17
Pathophysiology of ischaemia-reperfusion injury
Carden, D. L., & Granger, D. N. (2000) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(200002)190:3 · Cited by 5
Cited by
Matrix metalloproteinases and tumor metastasis
Deryugina, E. I., & Quigley, J. P. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-7886-9 · Cited by 1,960
RAS oncogenes: weaving a tumorigenic web
Pylayeva-Gupta, Y., Grabocka, E., & Bar-Sagi, D. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3106 · Cited by 1,789
Davis, G. E., & Senger, D. R. (2005) · Circulation Research · doi:10.1161/01.res.0000191547.64391.e3 · Cited by 1,223
uPAR: a versatile signalling orchestrator
Blasi, F., & Carmeliet, P. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm977 · Cited by 1,223
Adipose Tissue Remodeling: Its Role in Energy Metabolism and Metabolic Disorders
Choe, S. S., Huh, J. Y., Hwang, I. J., Kim, J. I., & Kim, J. B. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00030 · Cited by 1,206
Metadata
- Authors
- Pepper, M. S.
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 2001-07
- Volume
- 21
- Issue
- 7
- Pages
- 1104-1117
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2146519773
- Cited by
- 777
- References
- 143
- FWCI
- 18.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.